Home > Neurology > EAN 2022 > Miscellaneous > European survey of patient satisfaction in the treatment of cancer-related neuropathic pain

European survey of patient satisfaction in the treatment of cancer-related neuropathic pain

Presented By
‪Prof. Martin Rakusa, ‬University Medical Centre Maribor, Slovenia
Conference
EAN 2022
Doi
https://doi.org/10.55788/b2230c47
A European survey has gathered insights into the diagnosis and management of cancer-related neuropathic pain (CRNP) and its impact on patients. Major differences were found between European countries. High patient satisfaction was associated with healthcare professionals taking more time for their patients. Neuropathic pain is a common long-term consequence of cancer and its treatments. It can be directly disease-related or be due to the chosen treatment strategy. Continuing advances in chemotherapy, surgery, and radiotherapy significantly prolong survival, but can also prolong sequelae such as neuropathic pain. In order to gain better understanding of the needs of patients with CRNP and to give them a voice, an online survey was prepared, conducted, and analysed with a team of experts including physicians, nurses, and patients [1]. Adult cancer patients from 13 European countries were screened for symptoms of CRNP. If they met ≥3 criteria...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on